Updated:
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388320, and its reported...
Overview
Actinium Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388320, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-30, it reported annual revenue of USD 90,000; net income of USD -33,887,000; total assets of USD 51,775,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Actinium Pharmaceuticals, Inc.
- Former names in filing history
- Cactus Ventures, Inc. (2007-02-05 to 2013-03-29)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- NYSE: ATNM
- SEC CIK
- 0001388320
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $90,000 | -$33.9M | $51.8M | $48.0M | -$24.6M | |
| FY2024USD | — | -$38.2M | $76.9M | $72.9M | -$33.1M | |
| FY2023USD | $81,000 | -$48.8M | $81.4M | $76.7M | -$47.3M | |
| FY2022USD | $1.0M | -$33.0M | $114.2M | $108.9M | $8.6M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-K | ANNUAL REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| DEF 14A | PROXY STATEMENT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-Q | QUARTERLY REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Actinium Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.